{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:25:26Z","timestamp":1767651926172},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>The clinical characteristics associated with pulmonary function decline in patients with Tuberculosis-destroyed lung (TDL) remain uncertain. We categorize them based on the pattern of pulmonary function impairment, distinguishing between restrictive spirometric pattern (RSP) and obstructive spirometric pattern (OSP). We aim to compare the severity of these patterns with the clinical characteristics of TDL patients and analyze their correlation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We conducted a retrospective analysis on the clinical data of TDL patients who underwent consecutive pulmonary function tests (PFT) from November 2002 to February 2023. We used the lower limit formula for normal values based on the 2012 Global Lung Function Initiative. We compared the clinical characteristics of RSP patients with those of OSP patients. The characteristics of RSP patients were analyzed using the tertiles of forced vital capacity percentage predicted (FVC% pred) decline based on PFT measurements, and the characteristics of OSP patients were analyzed using the tertiles of forced expiratory volume in 1\u00a0s percentage predicted (FEV<jats:sub>1<\/jats:sub>% pred) decline.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Among the RSP patients, those in the Tertile1 group (with lower FVC% pred) were more likely to have a higher of body mass index (BMI), spinal deformities, and C-reactive protein (CRP) compared to the other two groups (<jats:italic>P for trend<\/jats:italic>\u2009&lt;\u20090.001, 0.027, and 0.013, respectively). Among OSP patients, those in the Tertile1 group (with lower FEV<jats:sub>1<\/jats:sub>% pred) showed an increasing trend in cough symptoms and contralateral lung infection compared to the Tertile 2\u20133 group (<jats:italic>P for trend<\/jats:italic> 0.036 and 0.009, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>For TDL patients, we observed that Patients with high BMI, a higher proportion of spinal scoliosis, and abnormal elevation of CRP levels were more likely to have reduced FVC. Patients with decreased FEV<jats:sub>1<\/jats:sub>% pred have more frequent cough symptoms and a higher proportion of lung infections on the affected side.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-024-03115-5","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T05:01:42Z","timestamp":1719205302000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of clinical characteristics of different types of lung function impaiement in TDL patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoman","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YunSong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyun","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"issue":"3","key":"3115_CR1","doi-asserted-by":"publisher","first-page":"950","DOI":"10.21037\/jtd-22-1799","volume":"15","author":"DW Park","year":"2023","unstructured":"Park DW, Kim BG, Jeong YH, et al. Risk of short- and long-term pulmonary complications should be determined before surgery for tuberculosis-destroyed lung. J Thorac Dis. 2023;15(3):950\u20132.","journal-title":"J Thorac Dis"},{"issue":"1","key":"3115_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5588\/ijtld.12.0351","volume":"17","author":"JH RHEE C K, YOO K H, LEE","year":"2013","unstructured":"RHEE C K, YOO K H, LEE JH, et al. Clinical characteristics of patients with tuberculosis-destroyed lung[J]. Int J Tuberc Lung Dis. 2013;17(1):67\u201375.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"3115_CR3","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"BAGCCHI S","year":"2023","unstructured":"BAGCCHI S. WHO\u2019s Global Tuberculosis Report 2022[J]. Lancet Microbe. 2023;4(1):e20.","journal-title":"Lancet Microbe"},{"issue":"4","key":"3115_CR4","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/S1473-3099(22)00875-1","volume":"23","author":"J DOM\u00edNGUEZ","year":"2023","unstructured":"DOM\u00edNGUEZ J, BOEREE M J CAMBAUE, et al. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet\/RESIST-TB consensus statement[J]. Lancet Infect Dis. 2023;23(4):e122\u201337.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3115_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jinf.2023.06.014","volume":"87","author":"M PEDERSEN O S, HOLMGAARD F B, MIKKEL","year":"2023","unstructured":"PEDERSEN O S, HOLMGAARD F B, MIKKELSEN M, et al. Global treatment outcomes of extensively drug-resistant tuberculosis in adults: a systematic review and meta-analysis[J]. J Infect. 2023;87(3):177\u201389.","journal-title":"J Infect"},{"issue":"10411","key":"3115_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/S0140-6736(23)01379-X","volume":"402","author":"M REID","year":"2023","unstructured":"REID M, AGBASSI Y, ARINAMINPATHY N, et al. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis[J]. Lancet. 2023;402(10411):1473\u201398.","journal-title":"Lancet"},{"issue":"10","key":"3115_CR7","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.21037\/jtd-22-610","volume":"14","author":"H RUAN","year":"2022","unstructured":"RUAN H, LI Y, WANG Y, et al. Risk factors for respiratory failure after tuberculosis-destroyed lung surgery and increased dyspnea score at 1-year follow-up[J]. J Thorac Dis. 2022;14(10):3737\u201347.","journal-title":"J Thorac Dis"},{"issue":"8","key":"3115_CR8","doi-asserted-by":"publisher","first-page":"e1008742","DOI":"10.1371\/journal.ppat.1008742","volume":"16","author":"BONGOMIN F","year":"2020","unstructured":"BONGOMIN F. Post-tuberculosis chronic pulmonary aspergillosis: an emerging public health concern[J]. PLoS Pathog. 2020;16(8):e1008742.","journal-title":"PLoS Pathog"},{"issue":"2","key":"3115_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ejcts.2011.05.028","volume":"41","author":"L BAI","year":"2012","unstructured":"BAI L, HONG Z, GONG C, et al. Surgical treatment efficacy in 172 cases of tuberculosis-destroyed lungs[J]. Eur J Cardiothorac Surg. 2012;41(2):335\u201340.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"7","key":"3115_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1055\/s-0036-1583524","volume":"65","author":"Y LI","year":"2017","unstructured":"LI Y, HU X. Pneumonectomy for treatment of destroyed lung: a retrospective study of 137 Patients[J]. Thorac Cardiovasc Surg. 2017;65(7):528\u201334.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"2","key":"3115_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13244-017-0547-4","volume":"8","author":"D Varona Porres","year":"2017","unstructured":"Varona Porres D, Persiva O, Pallisa E, Andreu J. Radiological findings of unilateral tuberculous lung destruction. Insights Imaging. 2017;8(2):271\u20137.","journal-title":"Insights Imaging"},{"issue":"1","key":"3115_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12890-022-02139-z","volume":"22","author":"H RUAN","year":"2022","unstructured":"RUAN H, LIU F, LI Y, et al. Long-term follow-up of tuberculosis-destroyed lung patients after surgical treatment[J]. BMC Pulm Med. 2022;22(1):346.","journal-title":"BMC Pulm Med"},{"issue":"6","key":"3115_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.mayocp.2018.04.009","volume":"93","author":"PD DEMPSEY T M, SCANLON","year":"2018","unstructured":"DEMPSEY T M, SCANLON PD. Pulmonary function tests for the generalist: a brief Review[J]. Mayo Clin Proc. 2018;93(6):763\u201371.","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"3115_CR14","first-page":"565","volume":"105","author":"S MAJUMDAR","year":"2007","unstructured":"MAJUMDAR S, SEN S, MANDAL S K. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases[J]. J Indian Med Assoc. 2007;105(10):565\u20136. 568, 570 passim.","journal-title":"J Indian Med Assoc"},{"issue":"11","key":"3115_CR15","doi-asserted-by":"publisher","first-page":"e0260274","DOI":"10.1371\/journal.pone.0260274","volume":"16","author":"SHINB LEE M K, KIM S B","year":"2021","unstructured":"LEE M K, KIM S B SHINB. Differences in the clinical characteristics of chronic pulmonary aspergillosis according to spirometric impairment[J]. PLoS ONE. 2021;16(11):e0260274.","journal-title":"PLoS ONE"},{"issue":"5","key":"3115_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","volume":"195","author":"VOGELMEIER C F","year":"2017","unstructured":"VOGELMEIER C F, CRINER G J, MARTINEZ F J, et al. Global strategy for the diagnosis, management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary[J]. Am J Respir Crit Care Med. 2017;195(5):557\u201382.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3115_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1345\/aph.1D230","volume":"38","author":"JM TOVAR","year":"2004","unstructured":"TOVAR JM, GUMS JG. Monitoring pulmonary function in asthma and COPD: point-of-care testing[J]. Ann Pharmacother. 2004;38(1):126\u201333.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"3115_CR18","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R PELLEGRINO","year":"2005","unstructured":"PELLEGRINO R, VIEGI G. Interpretative strategies for lung function tests[J]. Eur Respir J. 2005;26(5):948\u201368.","journal-title":"Eur Respir J"},{"issue":"1","key":"3115_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/ejcts\/ezs259","volume":"43","author":"A TERZI","year":"2013","unstructured":"TERZI A, BERTOLACCINI L, GORLA A, et al. Surgery for the treatment of the tuberculosis-destroyed lung: to protect or not to protect the bronchial stump?[J]. Eur J Cardiothorac Surg. 2013;43(1):201.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"3115_CR20","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"S QUANJER P H, STANOJEVIC","year":"2012","unstructured":"QUANJER P H, STANOJEVIC S, COLE T J, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations[J]. Eur Respir J. 2012;40(6):1324\u201343.","journal-title":"Eur Respir J"},{"issue":"1","key":"3115_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12890-021-01641-0","volume":"21","author":"H RUAN","year":"2021","unstructured":"RUAN H, LIU F, HAN M, et al. Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung[J]. BMC Pulm Med. 2021;21(1):273.","journal-title":"BMC Pulm Med"},{"issue":"6","key":"3115_CR22","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0003-4975(97)00999-5","volume":"64","author":"S HALEZEROGLU","year":"1997","unstructured":"HALEZEROGLU S, KELES M, UYSAL A, et al. Factors affecting postoperative morbidity and mortality in destroyed lung[J]. Ann Thorac Surg. 1997;64(6):1635\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"3115_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13073-021-00914-x","volume":"13","author":"M WIELSCHER","year":"2021","unstructured":"WIELSCHER M, AMARAL A, VAN DER PLAAT D, et al. Genetic correlation and causal relationships between cardio-metabolic traits and lung function impairment[J]. Genome Med. 2021;13(1):104.","journal-title":"Genome Med"},{"issue":"2","key":"3115_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pulmoe.2020.04.003","volume":"28","author":"L BALTIERI","year":"2022","unstructured":"BALTIERI L, CAZZO E, OLIVEIRA MODENA D A, et al. Correlation between levels of adipokines and inflammatory mediators with spirometric parameters in individuals with obesity and symptoms of asthma: cross-sectional study[J]. Pulmonology. 2022;28(2):105\u201312.","journal-title":"Pulmonology"},{"issue":"10","key":"3115_CR25","first-page":"963","volume":"5","author":"JH PARK","year":"2001","unstructured":"PARK JH, NA J O KIMEK, et al. The prognosis of respiratory failure in patients with tuberculous destroyed lung[J]. Int J Tuberc Lung Dis. 2001;5(10):963\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"3115_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4046\/trd.2018.0050","volume":"82","author":"YM KIM T H, RHEE C K, OH","year":"2019","unstructured":"KIM T H, RHEE C K, OH YM. Factors Associated with Indacaterol Response in tuberculosis-destroyed lung with Airflow Limitation[J]. Tuberc Respir Dis (Seoul). 2019;82(1):35\u201341.","journal-title":"Tuberc Respir Dis (Seoul)"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03115-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T05:01:45Z","timestamp":1719205305000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03115-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3115"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03115-5","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,24]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design adhered to the principles outlined in the Helsinki Declaration. Approved by the Ethics Committee of Beijing Chest Hospital, Capital Medical University (Ethics No: Clinical Research 2018 (43)). Clinical data were extracted from the hospital\u2019s electronic medical records system. publication of such data does not compromise anonymity or confidentiality or breach local data protection laws. Any participants will fully anonymous. The Ethics Committee of Beijing Chest Hospital of Capital Medical University waived the written informed consent of the patients in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"292"}}